Johns Hopkins University: Communicable Diseases trials

The registry lists 12 Communicable Diseases studies with Johns Hopkins University as lead sponsor. 1 are open to participants now and 3 have results posted.

Phase 1 3Phase 2 2Phase 3 1No phase 7(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Administering NMT to Reestablish Infant Nasal Microbiome Diversity Following Intranasal Mupirocin TreatmentRecruitingNCT06805994Phase 1
• Peginterferon Lambda-1a for the Prevention and Treatment of SARS-CoV-2 (COVID-19) InfectionTerminatedNCT04344600Phase 2Results posted
• Community Central Line Infection Prevention TrialCompletedNCT02351258Not applicableResults posted
• Study of Bathing With Chlorhexidine Impregnated Cloths on Nosocomial Infections in the Pediatric Intensive Care UnitCompletedNCT00549393Phase 2/3Results posted
• Comparing Single Versus Repeat NMT on the Diversity of the Neonatal Nasal MicrobiomeActive, not recruitingNCT06283355Phase 1
• Feasibility and Safety Study of Parent-to-Child Nasal Microbiota TransplantActive, not recruitingNCT05695196Phase 1
• Clinical Characterization Protocol for Severe Infectious Diseases (CCPSEI)CompletedNCT04496466
• Post-Endoscopic Infection Rate Notifications to Improve the Delivery of CareCompletedNCT03922971Not applicable
• Neurologic Manifestations of the Arbovirus Infection in ColombiaCompletedNCT03206541
• Vaginal Microbiota, and STI/HIV Risk Among Adolescent Girls and Young WomenCompletedNCT03196492
• The Johns Hopkins Transplant Infectious Diseases Prospective Cohort StudyCompletedNCT01986504
• Surgical Site Infection Rate After Intra-Abdominal Surgery Using Negative Pressure Wound Therapy at Initial ClosureCompletedNCT01924884